Eylea HD 8 MG/0.07 ML vial 0.07ML
Ended Awarded
- Contract number
- SPE2DB25FDE95
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $101,108
Award facts
- Contract value 100% obligated
- $101,108.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $101,108.00, is a firm fixed-price delivery order for the provision of EYLEA HD 8 MG/0.07 ML VIAL 0.07ML, a specialized pharmaceutical product.
DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The contract covers an extensive portfolio of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables.
The current contract award is not associated with any set-aside designation, allowing DMS Pharmaceutical Group Inc. to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group Inc. provides a diverse array of pharmaceutical products to the DLA and other military healthcare facilities.
Quick answers
Who was awarded contract SPE2DB25FDE95?
SPE2DB25FDE95 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 3, 2024.
How much is contract SPE2DB25FDE95 worth?
The government has obligated $101,108 on SPE2DB25FDE95.
Is contract SPE2DB25FDE95 an order under another contract?
Yes. SPE2DB25FDE95 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDE95 competed?
The extent of competition for SPE2DB25FDE95 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award